Literature DB >> 6467675

Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum.

J Taverne, N Matthews, P Depledge, J H Playfair.   

Abstract

Tumour necrosis serum (TNS), from animals primed with macrophage activating agents and challenged with endotoxin, causes necrosis of some tumours and can kill certain tumour lines in vitro and malarial parasites in vitro and in vivo. We have tested the possibility that the same factor is responsible for killing both tumour cells and malarial parasites. In competitive inhibition experiments, parasitized erythrocytes, but not normal erythrocytes, inhibited the cytotoxicity of TNS against a tumour cell line. Conversely, the tumour cells inhibited the killing of Plasmodium yoelii in vitro by TNS. When rabbit TNS was fractionated by ion exchange chromatography followed by gel filtration and the fractions at each step were pooled according to their ability to kill the tumour cells, in vitro parasite killing activity was found to correlate with tumour cell cytotoxicity, to a final sample which was purified more than 600-fold. Our results suggest that in terms of function, at least, the same component of TNS is responsible for the killing of both tumour cells and malarial parasites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467675      PMCID: PMC1536137     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours.

Authors:  C Mazurek; H Chalvet; C L Stiffel; G Biozzi
Journal:  Int J Cancer       Date:  1976-04-15       Impact factor: 7.396

2.  Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor.

Authors:  J M Ostrove; G E Gifford
Journal:  Proc Soc Exp Biol Med       Date:  1979-03

3.  Plasmodium yoelii and Plasmodium berghei: isolation of infected erythrocytes from blood by colloidal silica gradient centrifugation.

Authors:  C E Tosta; M Sedegah; D C Henderson; N Wedderburn
Journal:  Exp Parasitol       Date:  1980-08       Impact factor: 2.011

Review 4.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

5.  Transferrin receptors during rabbit reticulocyte maturation.

Authors:  F M van Bockxmeer; E H Morgan
Journal:  Biochim Biophys Acta       Date:  1979-04-18

6.  The protective effect of endogenous interferon in mouse malaria, as demonstrated by the use of anti-interferon globulins.

Authors:  F Sauvaget; B Fauconnier
Journal:  Biomedicine       Date:  1978-10

7.  Transferrin and transferrin receptors in carcinoma of the breast.

Authors:  W P Faulk; B L Hsi; P J Stevens
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

8.  Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties.

Authors:  N Matthews; J F Watkins
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

9.  Tumour-necrosis factor from the rabbit. III. Relationship to interferons.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

10.  Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization.

Authors:  N Matthews; H C Ryley; M L Neale
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

View more
  24 in total

1.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Tumour necrosis factor, cholestatic jaundice, and chronic liver disease.

Authors:  A Jones; P J Selby; C Viner; S Hobbs; M E Gore; T J McElwain
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

3.  Tumour necrosis factor in synovial exudates.

Authors:  F S Di Giovine; G Nuki; G W Duff
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

4.  Macrophage functions in Biozzi mice.

Authors:  H M Dockrell; J Taverne; R Lelchuk; P Depledge; I N Brown; J H Playfair
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

5.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  Presence of tumour necrosis factor or a related factor in human basophil/mast cells.

Authors:  M Steffen; M Abboud; G K Potter; Y P Yung; M A Moore
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

7.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

8.  A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Authors:  D M Williams; D M Magee; L F Bonewald; J G Smith; C A Bleicker; G I Byrne; J Schachter
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  The role of T cells in pathogenesis and protective immunity to murine malaria.

Authors:  S Waki; S Uehara; K Kanbe; K Ono; M Suzuki; H Nariuchi
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

10.  Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease.

Authors:  T Moritz; N Niederle; J Baumann; D May; E Kurschel; R Osieka; J Kempeni; E Schlick; C G Schmidt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.